Evidence map›Paper›PMID 30284039›Full record

ReviewSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2019

ASCO, NCCN, MASCC/ESMO: a comparison of antiemetic guidelines for the treatment of chemotherapy-induced nausea and vomiting in adult patients.

Yasmeen Razvi, Stephanie Chan, Thomas McFarlane, Erin McKenzie, Pearl Zaki, Carlo DeAngelis, William Pidduck, Ahmad Bushehri, Edward Chow, Katarzyna Joanna Jerzak

Registry-linked trialAbstract readComparative StudyReview
PubMed Publisher
In one paragraph

Review in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04669132 (Efficacy of Olanzapine, Netupitant and Palonosetron in Controlling Nausea and Vomiting Associated With Highly Emetogenic Chemotherapy in Patients With Breast Cancer), which is not on this map. Cited by 88 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
88citing papers in PubMed, 7 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04669132 phase2completednot on this mapstarted 2020, after this paper: background citation

Efficacy of Olanzapine, Netupitant and Palonosetron in Controlling Nausea and Vomiting Associated With Highly Emetogenic Chemotherapy in Patients With Breast Cancer

TypeinterventionalSponsorInstituto Brasileiro de Controle do CancerRan2020 to 2022Enrolled50ConditionsNausea Post ChemotherapyArmsOlanzapine, Netupitant, Palonesetron
3 · Its place in the literature

Who cites it

88 citing papers in PubMed, 7 syntheses or guidelines pooled it.

  1. Pooled it
  2. Guideline
  3. Pooled it
  4. Pooled it
  5. Effects of PC6 acupressure on acute and delayed nausea and vomiting induced by chemotherapy in patients with malignant neoplasm: a meta-analysis.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2023
    Pooled it
  6. Pooled it
  7. SEOM clinical guideline emesis (2021).Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2022
    Guideline
  8. Trial
  9. Trial
  10. Trial
  11. Auriculotherapy and acupuncture treatments for chemotherapy-induced nausea and vomiting: a multicenter clinical trial.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2024
    Trial
  12. Trial
  13. Trial
  14. Trial
  15. Trial
  16. Trial
  17. Trial
  18. Trial
  19. Trial
  20. A phase III study of transdermal granisetron versus oral ondansetron for women with gynecologic cancers receiving pelvic chemoradiation.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2021
    Trial

28 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Yasmeen RazviSunnybrook Odette Cancer Centre, University of Toronto, Toronto, ON, Canada.
Stephanie ChanSunnybrook Odette Cancer Centre, University of Toronto, Toronto, ON, Canada.
Thomas McFarlaneSunnybrook Odette Cancer Centre, University of Toronto, Toronto, ON, Canada.
Erin McKenzieSunnybrook Odette Cancer Centre, University of Toronto, Toronto, ON, Canada.
Pearl ZakiSunnybrook Odette Cancer Centre, University of Toronto, Toronto, ON, Canada.
Carlo DeAngelisSunnybrook Odette Cancer Centre, University of Toronto, Toronto, ON, Canada.
William PidduckSunnybrook Odette Cancer Centre, University of Toronto, Toronto, ON, Canada.
Ahmad BushehriSunnybrook Odette Cancer Centre, University of Toronto, Toronto, ON, Canada.
Edward ChowSunnybrook Odette Cancer Centre, University of Toronto, Toronto, ON, Canada.
Katarzyna Joanna JerzakSunnybrook Odette Cancer Centre, University of Toronto, Toronto, ON, Canada. Katarzyna.Jerzak@sunnybrook.ca.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chemotherapy-induced nausea and vomiting (CINV) is a common toxicity that may impair the quality of life of patients with a variety of early- and end-stage malignancies. In light of recent changes in the optimal management of CINV, we undertook this narrative review to compare the latest guidelines published by ASCO (2017), NCCN (2018), and MASCC/ESMO (2016). The processes undertaken by each organization to evaluate existing literature were also described. Although ASCO, NCCN, and MASCC/ESMO guidelines for the treatment and prevention of CINV share many fundamental similarities, literature surrounding low and minimal emetic risk regimens is lacking. Data regarding the use of complementary alternative medicine for CINV is particularly scarce and in need of further investigation.

Indexed as

Practice Guidelines as TopicAdultAntiemeticsAntineoplastic Combined Chemotherapy ProtocolsHumansNauseaNeoplasmsPractice Patterns, Physicians'Quality of LifeSocieties, MedicalVomitingAntiemeticsAntiemeticChemotherapy-induced nausea and vomitingGuidelinesProphylaxis

Identifiers

PMID30284039

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.